News Overview

The Company has resumed operations at its Kalyan plant with effect from March 20, 2022 in a phased manner.

The Prior Approval Supplement (PAS) received was for a site transfer into the Jarod site.

The domestic equity barometers ended at the days low on Monday. The Nifty closed below the 17,150 level. Barring metals, most the sectoral indices on the NSE ended in the red As per provisional closing data, the barometer index, the S&P BSE Sensex, fell 571.44 points or 0.99% to 57,292.49. The Nifty 50 index lost 169.45 points or 0.98% to 17,117.60. In the broader market, […]

Recognition honors companies demonstrating exceptional leadership and a commitment to business integrity through best-in-class ethics, compliance, and governance practices.

Granules India advanced 2.98% to Rs 314.50 after the company received a license from Medicines Patent Pool (MPP) to manufacture and market generic versions of Pfizers oral treatment Nirmatrelvir, co-packaged with Ritonavir for treatment of COVID-19.

With effect from 21 March 2022

Senior citizens can now earn maximum benefits as the Bank offers them a flat rate of 0.50% extra over existing revised rates on RTDs.

K E C International has secured new orders worth Rs 1005 crore across its various businesses. Powered by Capital Market – Live News

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg, and 200 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Vimpat Tablets, 50 mg, 100 mg, 150 mg, and 200 mg, of UCB, Inc. Lacosamide […]

Record date is 12 April 2022